A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

By Arnoletti J.   Frolov A.   Eloubeidi M.   Keene K.   Posey J.   Wood T.   Greeno Edward   Jhala N.   Varadarajulu S.   Russo S.   Christein J.   Oster R.   Buchsbaum D.   Vickers S.  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite

Multiple Infusions of Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (EMD 55 900) in Patients with Recurrent Malignant Gliomas

By Stragliotto G.   Vega F.   Stasiecki P.   Gropp P.   Poisson M.   Delattre J.-Y.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 636-640

Elsevier

Access to resources Recommend Favorite

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma

By Okuda K.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1105-1111

Springer Publishing Company

Access to resources Recommend Favorite

Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

By Waksal H.W.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies for Advanced Breast Cancer

By Campos Susana  

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 757-768

Informa Healthcare

Access to resources Recommend Favorite